These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18333608)

  • 41. Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling.
    Bjij I; Ramharack P; Khan S; Cherqaoui D; Soliman MES
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31466292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of Potent Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 Using a Novel Growth-Based Protocol of
    Liu Z; Singh SB; Zheng Y; Lindblom P; Tice C; Dong C; Zhuang L; Zhao Y; Kruk BA; Lala D; Claremon DA; McGeehan GM; Gregg RD; Cain R
    J Chem Inf Model; 2019 Aug; 59(8):3422-3436. PubMed ID: 31355641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors.
    Sandanayaka VP; Prashad AS
    Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination.
    Woods LA; Dolezal O; Ren B; Ryan JH; Peat TS; Poulsen SA
    J Med Chem; 2016 Mar; 59(5):2192-204. PubMed ID: 26882437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A high-throughput screen for aggregation-based inhibition in a large compound library.
    Feng BY; Simeonov A; Jadhav A; Babaoglu K; Inglese J; Shoichet BK; Austin CP
    J Med Chem; 2007 May; 50(10):2385-90. PubMed ID: 17447748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
    Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
    J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N
    Zhong W; Koay A; Ngo A; Li Y; Nah Q; Wong YH; Chionh YH; Ng HQ; Koh-Stenta X; Poulsen A; Foo K; McBee M; Choong ML; El Sahili A; Kang C; Matter A; Lescar J; Hill J; Dedon P
    ACS Infect Dis; 2019 Mar; 5(3):326-335. PubMed ID: 30682246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of OXA-1 beta-lactamase by penems.
    Bethel CR; Distler AM; Ruszczycky MW; Carey MP; Carey PR; Hujer AM; Taracila M; Helfand MS; Thomson JM; Kalp M; Anderson VE; Leonard DA; Hujer KM; Abe T; Venkatesan AM; Mansour TS; Bonomo RA
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3135-43. PubMed ID: 18559643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mass spectrometric studies on the inhibition of TEM-2 beta-lactamase by clavulanic acid derivatives.
    Brown RP; Aplin RT; Schofield CJ; Frydrych CH
    J Antibiot (Tokyo); 1997 Feb; 50(2):184-5. PubMed ID: 9099233
    [No Abstract]   [Full Text] [Related]  

  • 51. Hsp90 inhibitors and drugs from fragment and virtual screening.
    Roughley S; Wright L; Brough P; Massey A; Hubbard RE
    Top Curr Chem; 2012; 317():61-82. PubMed ID: 21647838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.
    Helfand MS; Bethel CR; Hujer AM; Hujer KM; Anderson VE; Bonomo RA
    J Biol Chem; 2003 Dec; 278(52):52724-9. PubMed ID: 14534312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,).
    Ness S; Martin R; Kindler AM; Paetzel M; Gold M; Jensen SE; Jones JB; Strynadka NC
    Biochemistry; 2000 May; 39(18):5312-21. PubMed ID: 10820001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virtual high-throughput screens identifying hPK-M2 inhibitors: Exploration of model extrapolation.
    Chen JJ; Schmucker LN; Visco DP
    Comput Biol Chem; 2019 Feb; 78():317-329. PubMed ID: 30623877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. beta-Lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors.
    Payne DJ; Du W; Bateson JH
    Expert Opin Investig Drugs; 2000 Feb; 9(2):247-61. PubMed ID: 11060675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors.
    Yousuf M; Shaikh NN; Ul-Haq Z; Choudhary MI
    PLoS One; 2018; 13(12):e0200502. PubMed ID: 30517092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Luciferase Advisor: High-Accuracy Model To Flag False Positive Hits in Luciferase HTS Assays.
    Ghosh D; Koch U; Hadian K; Sattler M; Tetko IV
    J Chem Inf Model; 2018 May; 58(5):933-942. PubMed ID: 29667823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase.
    Evenäs J; Edfeldt F; Lepistö M; Svitacheva N; Synnergren A; Lundquist B; Gränse M; Rönnholm A; Varga M; Wright J; Wei M; Yue S; Wang J; Li C; Li X; Chen G; Liao Y; Lv G; Tjörnebo A; Narjes F
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1315-21. PubMed ID: 24508129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Docking covalent inhibitors: a parameter free approach to pose prediction and scoring.
    Zhu K; Borrelli KW; Greenwood JR; Day T; Abel R; Farid RS; Harder E
    J Chem Inf Model; 2014 Jul; 54(7):1932-40. PubMed ID: 24916536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.